Could a botox shot in the gut ease Kids' chronic vomiting?

NCT ID NCT04250844

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial tests whether injecting botulinum toxin into the pylorus—the muscle at the stomach's exit—can help children aged 30 days to 18 years who struggle with chronic nausea, vomiting, or feeding intolerance. Participants receive the injection during an upper endoscopy, and researchers track changes in quality of life and symptom severity over four weeks. The goal is to see if relaxing this muscle improves how well children tolerate feeds and reduces distressing symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
intrapyloric botulinum toxin injections
What this could lead to
If effective, this could offer a minimally invasive option to ease chronic nausea, vomiting, and feeding difficulties in children, improving their daily comfort and quality of life.
What could go wrong
This is an early-stage study, and results may not confirm benefit. Risks include procedure-related complications and the possibility that the effect is temporary or no better than a placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEEDING DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

eating disorder Feeding and Eating Disorders gastroparesis Vomiting

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Boston Children's Hospital

    Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.